Mackenzie Financial’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Mackenzie Financial’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,808	Closed	-$296K	–	713
2016 Q4	$296K	Sell	2,808 -5,050	-64%	-$529K	﹤0.01%	560
2016 Q3	$868K	Buy	7,858 +1,731	+28%	+$229K	0.01%	432
2016 Q2	$892K	Hold	6,127	–	–	0.01%	621
2016 Q1	$878K	Buy	+6,127	New	+$870K	0.01%	542

Other funds holding TARO

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Mackenzie Financial's TARO Position: Q1 2017 in Review

Mackenzie Financial sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2017, closing a stake of 2,808 shares — an estimated $296K sold.

Mackenzie Financial first reported a position in TARO in Q1 2016 and held it in 4 quarters. The position peaked at $892K in Q2 2016. 139 funds tracked by Wall St. Rank hold TARO as of Q1 2017.

Mackenzie Financial reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2017 after selling out during the quarter.
Mackenzie Financial sold 2,808 Taro Pharmaceutical Industries Ltd. shares in Q1 2017, an estimated $296K.
Mackenzie Financial first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 4 quarters.
Mackenzie Financial's Taro Pharmaceutical Industries Ltd. position peaked at $892K in Q2 2016.
139 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2017.

Based on Mackenzie Financial's 13F filing for Q1 2017, filed 12 May 2017.